The largest database of trusted experimental protocols

8 protocols using cd11a

1

Multiparameter Phosphoprotein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Abs directed against phosphotyrosine (PY1000), phospho–spleen tyrosine kinase (Syk) (Y525/526), phospho-pan Src (Y527 and Y416), phospho-Akt (S473), phospho-p38 (T180, Y182), and phospho-Erk (T202, Y204) were from Cell Signaling Technology. Anti-Syk (clone 5F5) and anti-Lyn (clone LYN-01) were from BioLegend. Anti-Ly6G (clone RC6-8C5) was obtained from R&D Systems. Anti-BSA and anti-lactoferrin Abs were from Sigma and an Ab against β-COP was a gift from Nick Ktistakis (The Babraham Institute, Cambridge, U.K.). HRP-conjugated secondary Abs were from Santa Cruz Biotechnology and Bio-Rad. Fluorescently conjugated Abs for flow cytometry were obtained from eBioscience (F4/80, GR1), BioLegend (CD11b, CD11a, CD16/32, Ly6G, CD62L, CD19), and BD (Ly6C).
+ Open protocol
+ Expand
2

Transwell Migration Assay for PMN Infiltration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human epithelial cells were cultivated on inserts of a Transwell system (Costar, MA, USA) until reaching confluence. Thereby, cells were seeded on the bottom side of the inserts, so that cells migrate—comparable to the in vivo migration—from the basolateral side through the epithelial monolayer. PMNs from whole human blood migrated through a monolayer of epithelial cells along a chemotactic gradient (fMLP; 20 ng/ml; Sigma-Aldrich, Steinheim, Germany) (Supplemental Figure 3). After 4 h, PMNs in the upper chamber and also migrated PMNs in the lower chamber were collected. To determine PMNs in the epithelial layer, wells were treated with 800 μl Accutase and incubated and washed with 2 ml medium. Absolute cell counts were determined. PMNs were identified CD45 (B183057, BioLegend) and CD66b (E16847-109 eBioscience) positive, adhesion molecules by: CD11a (catalog number 3189709, BD), CD11b (54342, BD), CD31 (4065855, BD), CD54 (4301917, BD), CD162 (61514, BD), CD47 (E15361-103, eBioscience), CD172a (3290897, BD), CD44 (B180554, BioLegend), and CD29 (4262918, BD). As corresponding IgG controls were IgG1 (16651, BD) and IgM (E13114-104, eBioscience) used.
+ Open protocol
+ Expand
3

Characterization of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
AMSCs were grown in Dulbecco’s modified Eagle’s medium (L-DMEM), IMDM, DF12 (Life Technologies, San Diego, CA, USA), with platelet-derived growth factor BB (PDGF-BB, Sigma, St. Louis, MO, USA). The following antibodies were used: CD11a, CD29, CD31, CD34, CD44, CD45, CD73, CD105, CD106, CD166, CD184, HLA-ABC, HLA-DR (BD Biosciences, San Jose, CA, USA); anti-rabbit IgG- fluorescein isothiocyanate (FITC; Sigma), anti-mouse IgG-FITC (Sigma). Jagged-1 (Calbiochem, San Diego, CA); Jagged-2 (Chemicon, Temecula, CA); Delta-1(Santa Cruz Biotechnology, CA).
+ Open protocol
+ Expand
4

Blocking ICAM-1 and LFA-1 in CD4+ T cell activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blocking antibodies against ICAM-1 (CD54) and LFA-1 (CD11a), and matched isotype control IgG1 (all BD Biosciences) were added to the CD4+ T cell/vaccine cell co-cultures at boosting in a concentration range of 0,2-5μg/ml. Mel202 and Mel202/DR1/CD80 cells were analyzed for ICAM-1 expression, and vaccine-activated CD4+ T cells were analyzed for LFA-1 expression by flow cytometry.
+ Open protocol
+ Expand
5

Characterization of Cell Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following fluorescein (FITC)-, allophycocyanin (APC)-or phycoerythrin (PE)-conjugated mouse anti-human monoclonal antibodies (mAbs) were used: Anti-CD10, -CD11a, CD11c, -CD18, -CD33, -CD40, -CDD44std, -CD44v5, -CD44v6, -CD54, -CD61, -CD62P, -CD86, -CD133, -CD206 (MR), -EGFR, -Her-2/neu, -HLA-DR, HLA class I, -CCR5, -CCR6, Her-2/neu all from BD Pharmingen (San Diego, CA, USA); anti-CD29, -CD36, -CD51, -CD58 from Immunotech (Marseille, France); anti-c-MET, -CCR1, -CCR2, -CCR3, -CCR7, -CXCR1, -CXCR2, -CXCR4 from R&D (Abington, UK); anti-Tag72, -Mucin1 (EMA, CD227), -EMMPRIN from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA) and anti-Epithelial Antigen, -Epithelial Membrane Antigen (EMA) from DAKO (Heverlee, Belgium). Isotype controls included appropriate FITC-, APC- or PE-labeled mouse IgG1, IgG2a or IgG2b. Cells were incubated with mAbs or isotype controls for 20 min at 4°C, washed, resuspended in PBS and analyzed by flow cytometry (FACS Canto; BD Biosciences Immunocytometry Systems, San Jose, CA, USA) using FACS DiVa software.
+ Open protocol
+ Expand
6

Investigating Immune Cell Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used as follow: For flow cytometry determination, CD3, CD8, CD54 (intercellular adhesion molecule [ICAM]-1), CD106 (vascular adhesion molecule [VCAM]-1), CD11a (lymphocyte function-associated antigen-1 [LFA-1]), CD29 (integrin β1), IL-27, IFN-γ, IL-17, phosphorylated (p)-STAT1 (pY701), p-STAT1 (pS727), p-STAT2 (pY689), p-STAT3 (pS727), p-STAT3 (pY705), p-STAT4 (pY693), p-STAT5 (pY694), p-STAT6 (pY641), TCCR-WSX-1 (IL-27 receptor), IL-17 receptor (R), IFN-γR1, and Ki-67 mAbs were purchased from BD Biosciences (Franklin Lakes, USA), eBioscience (San Diego, USA), or R and D systems (Minneapolis, USA); for cytokine neutralization, IL-27, IFN-γ, IL-17, ICAM-1 and VCAM-1 mAbs were from eBioscience.
Recombinant human IL-27, IFN-γ, IL-17A were purchased from R and D systems or eBioscience. STAT1 inhibitor S14-95 and STAT3 inhibitor Galiellalactone were from Enzo Life Sciences (Farmingdale, USA). Annexin V Apoptosis Detection Kit was from eBioscience. PMA and ionomycin were from Sigma-Aldrich (St. Louis, USA), and GolgiPlug and GolgiStop were from BD Bioscience. Foxp3 fixation/permeabilization concentrate and diluent were from eBioscience. Fluorescent dye CFSE was from Invitrogen (Carlsbad, USA).
+ Open protocol
+ Expand
7

Phenotypic Characterization of hUC-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was used to analyze the phenotype of hUC-MSCs. Trypsinized cells were suspended in phosphate-buffered saline (catalog no. PBS-10001, Cyagen Biosciences, Inc.) at a density of 5 × 106 cells/ml, and a 100 μl sample was incubated with various BD Pharmingen™ PE mouse anti-human CD73 (catalog no. 561014, 1 : 50), CD105 (catalog no. 560839, 1 : 50), CD34 (catalog no. 560941, 1 : 50), and BD Pharmingen™ FITC mouse anti-human CD90 (catalog no. 561969, 1 : 50), CD45 (catalog no. 560976, 1 : 50), CD11a (catalog no. 555383, 1 : 50), and HLA-DR (catalog no. 560944, 1 : 50) antibodies (BD Biosciences) for 45 min at room temperature. Control samples were incubated with PBS instead of antibodies. Antibody binding was examined using a FACScan flow cytometer (Beckman Coulter) and was analyzed using FlowJo v10.6.2 (BD Biosciences).
+ Open protocol
+ Expand
8

Coverslip Preparation for Imaging Spread Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The preparation of coverslips for imaging spread cells followed a previously described technique (e.g. 2 ). Briefly, for diffraction limited and PALM imaging, coverslips (#1.5 glass chambers, LabTek or iBidi) were washed with acidic ethanol at room temperature (RT) for 10 min; liquid was then aspirated and coverslips were dried at 40°C for 1 hour.
Cleaned coverslips were incubated at RT for 15 min with 0.01% poly-L-lysine (Sigma) diluted in water. Liquid was aspirated and coverslips were dried at 40°C for 12 hours.
Coverslips were subsequently incubated with stimulatory or non-stimulatory antibodies at a concentration of 10 mg/ml (unless specified otherwise) overnight at 4°C or 2 hours at 37°C. Finally, coverslips were washed with PBS. Throughout the study we used the following stimulatory antibodies: purified mouse anti human CD3 (clone Ucht1) and CD11a (BD Biosciences). A few minutes before imaging, cells were resuspended in imaging buffer at a concentration of 1 million/150 ml and 100,000-500,000 cells were dropped onto coverslips for PALM or diffraction limited imaging, incubated at 37°C for the specific spreading time (typically 3 min) and fixed with 2.4% PFA for 30 min at 37°C or used for live cell imaging.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!